Loading…
Metabolism of the Catharanthus Alkaloids: from Streptomyces griseus to Monoamine Oxidase B
More than three decades after their discovery and implementation in medicine, essentially nothing is known about the metabolism or the implications of metabolism in mechanism of action or toxicity of the Catharanthus alkaloids. The frustrating paucity of information about pathways of metabolism has...
Saved in:
Published in: | Journal of natural products (Washington, D.C.) D.C.), 1992-03, Vol.55 (3), p.269-284 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a402t-b457a863e55cdee016a561abb5f29cb63151bb50e236ed43e004ea61a22cada03 |
---|---|
cites | |
container_end_page | 284 |
container_issue | 3 |
container_start_page | 269 |
container_title | Journal of natural products (Washington, D.C.) |
container_volume | 55 |
creator | Rosazza, John P. N Duffel, Michael W El-Marakby, Sayed Ahn, Sung Ho |
description | More than three decades after their discovery and implementation in medicine, essentially nothing is known about the metabolism or the implications of metabolism in mechanism of action or toxicity of the Catharanthus alkaloids. The frustrating paucity of information about pathways of metabolism has limited a major source of structure-activity relationship information and has blocked a critical avenue necessary for the logical development of new and more useful Catharanthus alkaloids. Microbial transformations, peroxidases, copper oxidases, mouse and rat cytochrome P-450 systems, and mouse brain and bovine liver monoamine oxidase (MAO) preparations have been explored in the study of Catharanthus alkaloid metabolism. In this report, we present results which have clarified the involvement of enzymatic and chemically catalyzed one-electron oxidations that yield nitrogen-centered cation radicals, iminium, and carbinolamine intermediates, all of which explain how new carbon-carbon and carbon-oxygen bonds form, or break and rearrange. The dimeric Catharanthus alkaloids are recalcitrant to oxidations catalyzed by monoamine oxidases and to both normal and induced P-450 rat microsomal preparations. However, the Catharanthus alkaloids appear to be selective reversible inhibitors of MAO-B. Chemical and biochemical aspects of the metabolic transformations of dimeric Catharanthus alkaloids are reviewed together with the implications of our findings. |
doi_str_mv | 10.1021/np50081a001 |
format | article |
fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_np50081a001</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_TPS_01MB76PS_G</sourcerecordid><originalsourceid>FETCH-LOGICAL-a402t-b457a863e55cdee016a561abb5f29cb63151bb50e236ed43e004ea61a22cada03</originalsourceid><addsrcrecordid>eNptkE1r3DAQhkVpSLdpT70VCjoUeghORp_ezS1ZmjSQJYVNLr2IsT3uOrGtRdJC8u-rxSHtoafR8D5Irx7GPgk4ESDF6bg1AHOBAOINmwkjobAgzVs2A2FVoeZWv2PvY3wAAAULc8gOhVkoWc5n7NeKEla-7-LAfcvThvgS0wYDjmmzi_y8f8Ted008423wA1-nQNvkh-eaIv8dukgZSp6v_Ohx6Ebit09dg5H4xQd20GIf6ePLPGL3l9_vlj-Km9ur6-X5TYEaZCoqbUqcW0XG1A1RrozGCqwq08pFXVkljMgLkFSWGq0IQBNmQsoaGwR1xI6ne-vgYwzUum3oBgzPToDbC3L_CMr0l4ne7qqBmr_sZCTnX19yjDX2bRZRd_EVM0JrqcuMFRPWxURPrzGGR2dLVRp393PtQKwuSpsPV5n_PPEteod7ce5-vX9R6P0Pvk0h1tE9-F0Ys6__tv8DgKCRWw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Metabolism of the Catharanthus Alkaloids: from Streptomyces griseus to Monoamine Oxidase B</title><source>ACS CRKN Legacy Archives</source><creator>Rosazza, John P. N ; Duffel, Michael W ; El-Marakby, Sayed ; Ahn, Sung Ho</creator><creatorcontrib>Rosazza, John P. N ; Duffel, Michael W ; El-Marakby, Sayed ; Ahn, Sung Ho</creatorcontrib><description>More than three decades after their discovery and implementation in medicine, essentially nothing is known about the metabolism or the implications of metabolism in mechanism of action or toxicity of the Catharanthus alkaloids. The frustrating paucity of information about pathways of metabolism has limited a major source of structure-activity relationship information and has blocked a critical avenue necessary for the logical development of new and more useful Catharanthus alkaloids. Microbial transformations, peroxidases, copper oxidases, mouse and rat cytochrome P-450 systems, and mouse brain and bovine liver monoamine oxidase (MAO) preparations have been explored in the study of Catharanthus alkaloid metabolism. In this report, we present results which have clarified the involvement of enzymatic and chemically catalyzed one-electron oxidations that yield nitrogen-centered cation radicals, iminium, and carbinolamine intermediates, all of which explain how new carbon-carbon and carbon-oxygen bonds form, or break and rearrange. The dimeric Catharanthus alkaloids are recalcitrant to oxidations catalyzed by monoamine oxidases and to both normal and induced P-450 rat microsomal preparations. However, the Catharanthus alkaloids appear to be selective reversible inhibitors of MAO-B. Chemical and biochemical aspects of the metabolic transformations of dimeric Catharanthus alkaloids are reviewed together with the implications of our findings.</description><identifier>ISSN: 0163-3864</identifier><identifier>EISSN: 1520-6025</identifier><identifier>DOI: 10.1021/np50081a001</identifier><identifier>PMID: 1593278</identifier><identifier>CODEN: JNPRDF</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>AGENTES ANTINEOPLASTICOS ; ALCALOIDE ; ALCALOIDES ; ALKALOIDS ; Animals ; ANTINEOPLASTIC AGENTS ; APOCYNACEAE ; Biological and medical sciences ; DRUG TOXICITY ; DRUGS ; FARMACOLOGIA ; General pharmacology ; Humans ; Medical sciences ; MEDICAMENT ; MEDICAMENT CYTOSTATIQUE ; MEDICAMENTOS ; METABOLISM ; METABOLISME ; METABOLISMO ; Monoamine Oxidase - metabolism ; Monoamine Oxidase Inhibitors - pharmacology ; PHARMACODYNAMICS ; Pharmacognosy. Homeopathy. Health food ; PHARMACOLOGIE ; PHARMACOLOGY ; Pharmacology. Drug treatments ; TOXICIDAD ; TOXICITE ; TOXICITY ; Vinca Alkaloids - metabolism ; Vinca Alkaloids - pharmacology</subject><ispartof>Journal of natural products (Washington, D.C.), 1992-03, Vol.55 (3), p.269-284</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a402t-b457a863e55cdee016a561abb5f29cb63151bb50e236ed43e004ea61a22cada03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/np50081a001$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/np50081a001$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,27062,27922,27923,56764,56814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5144247$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1593278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosazza, John P. N</creatorcontrib><creatorcontrib>Duffel, Michael W</creatorcontrib><creatorcontrib>El-Marakby, Sayed</creatorcontrib><creatorcontrib>Ahn, Sung Ho</creatorcontrib><title>Metabolism of the Catharanthus Alkaloids: from Streptomyces griseus to Monoamine Oxidase B</title><title>Journal of natural products (Washington, D.C.)</title><addtitle>J. Nat. Prod</addtitle><description>More than three decades after their discovery and implementation in medicine, essentially nothing is known about the metabolism or the implications of metabolism in mechanism of action or toxicity of the Catharanthus alkaloids. The frustrating paucity of information about pathways of metabolism has limited a major source of structure-activity relationship information and has blocked a critical avenue necessary for the logical development of new and more useful Catharanthus alkaloids. Microbial transformations, peroxidases, copper oxidases, mouse and rat cytochrome P-450 systems, and mouse brain and bovine liver monoamine oxidase (MAO) preparations have been explored in the study of Catharanthus alkaloid metabolism. In this report, we present results which have clarified the involvement of enzymatic and chemically catalyzed one-electron oxidations that yield nitrogen-centered cation radicals, iminium, and carbinolamine intermediates, all of which explain how new carbon-carbon and carbon-oxygen bonds form, or break and rearrange. The dimeric Catharanthus alkaloids are recalcitrant to oxidations catalyzed by monoamine oxidases and to both normal and induced P-450 rat microsomal preparations. However, the Catharanthus alkaloids appear to be selective reversible inhibitors of MAO-B. Chemical and biochemical aspects of the metabolic transformations of dimeric Catharanthus alkaloids are reviewed together with the implications of our findings.</description><subject>AGENTES ANTINEOPLASTICOS</subject><subject>ALCALOIDE</subject><subject>ALCALOIDES</subject><subject>ALKALOIDS</subject><subject>Animals</subject><subject>ANTINEOPLASTIC AGENTS</subject><subject>APOCYNACEAE</subject><subject>Biological and medical sciences</subject><subject>DRUG TOXICITY</subject><subject>DRUGS</subject><subject>FARMACOLOGIA</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>MEDICAMENT</subject><subject>MEDICAMENT CYTOSTATIQUE</subject><subject>MEDICAMENTOS</subject><subject>METABOLISM</subject><subject>METABOLISME</subject><subject>METABOLISMO</subject><subject>Monoamine Oxidase - metabolism</subject><subject>Monoamine Oxidase Inhibitors - pharmacology</subject><subject>PHARMACODYNAMICS</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>PHARMACOLOGIE</subject><subject>PHARMACOLOGY</subject><subject>Pharmacology. Drug treatments</subject><subject>TOXICIDAD</subject><subject>TOXICITE</subject><subject>TOXICITY</subject><subject>Vinca Alkaloids - metabolism</subject><subject>Vinca Alkaloids - pharmacology</subject><issn>0163-3864</issn><issn>1520-6025</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNptkE1r3DAQhkVpSLdpT70VCjoUeghORp_ezS1ZmjSQJYVNLr2IsT3uOrGtRdJC8u-rxSHtoafR8D5Irx7GPgk4ESDF6bg1AHOBAOINmwkjobAgzVs2A2FVoeZWv2PvY3wAAAULc8gOhVkoWc5n7NeKEla-7-LAfcvThvgS0wYDjmmzi_y8f8Ted008423wA1-nQNvkh-eaIv8dukgZSp6v_Ohx6Ebit09dg5H4xQd20GIf6ePLPGL3l9_vlj-Km9ur6-X5TYEaZCoqbUqcW0XG1A1RrozGCqwq08pFXVkljMgLkFSWGq0IQBNmQsoaGwR1xI6ne-vgYwzUum3oBgzPToDbC3L_CMr0l4ne7qqBmr_sZCTnX19yjDX2bRZRd_EVM0JrqcuMFRPWxURPrzGGR2dLVRp393PtQKwuSpsPV5n_PPEteod7ce5-vX9R6P0Pvk0h1tE9-F0Ys6__tv8DgKCRWw</recordid><startdate>19920301</startdate><enddate>19920301</enddate><creator>Rosazza, John P. N</creator><creator>Duffel, Michael W</creator><creator>El-Marakby, Sayed</creator><creator>Ahn, Sung Ho</creator><general>American Chemical Society</general><general>American Society of Pharmacognosy</general><scope>FBQ</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19920301</creationdate><title>Metabolism of the Catharanthus Alkaloids: from Streptomyces griseus to Monoamine Oxidase B</title><author>Rosazza, John P. N ; Duffel, Michael W ; El-Marakby, Sayed ; Ahn, Sung Ho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a402t-b457a863e55cdee016a561abb5f29cb63151bb50e236ed43e004ea61a22cada03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>AGENTES ANTINEOPLASTICOS</topic><topic>ALCALOIDE</topic><topic>ALCALOIDES</topic><topic>ALKALOIDS</topic><topic>Animals</topic><topic>ANTINEOPLASTIC AGENTS</topic><topic>APOCYNACEAE</topic><topic>Biological and medical sciences</topic><topic>DRUG TOXICITY</topic><topic>DRUGS</topic><topic>FARMACOLOGIA</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>MEDICAMENT</topic><topic>MEDICAMENT CYTOSTATIQUE</topic><topic>MEDICAMENTOS</topic><topic>METABOLISM</topic><topic>METABOLISME</topic><topic>METABOLISMO</topic><topic>Monoamine Oxidase - metabolism</topic><topic>Monoamine Oxidase Inhibitors - pharmacology</topic><topic>PHARMACODYNAMICS</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>PHARMACOLOGIE</topic><topic>PHARMACOLOGY</topic><topic>Pharmacology. Drug treatments</topic><topic>TOXICIDAD</topic><topic>TOXICITE</topic><topic>TOXICITY</topic><topic>Vinca Alkaloids - metabolism</topic><topic>Vinca Alkaloids - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosazza, John P. N</creatorcontrib><creatorcontrib>Duffel, Michael W</creatorcontrib><creatorcontrib>El-Marakby, Sayed</creatorcontrib><creatorcontrib>Ahn, Sung Ho</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of natural products (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosazza, John P. N</au><au>Duffel, Michael W</au><au>El-Marakby, Sayed</au><au>Ahn, Sung Ho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolism of the Catharanthus Alkaloids: from Streptomyces griseus to Monoamine Oxidase B</atitle><jtitle>Journal of natural products (Washington, D.C.)</jtitle><addtitle>J. Nat. Prod</addtitle><date>1992-03-01</date><risdate>1992</risdate><volume>55</volume><issue>3</issue><spage>269</spage><epage>284</epage><pages>269-284</pages><issn>0163-3864</issn><eissn>1520-6025</eissn><coden>JNPRDF</coden><abstract>More than three decades after their discovery and implementation in medicine, essentially nothing is known about the metabolism or the implications of metabolism in mechanism of action or toxicity of the Catharanthus alkaloids. The frustrating paucity of information about pathways of metabolism has limited a major source of structure-activity relationship information and has blocked a critical avenue necessary for the logical development of new and more useful Catharanthus alkaloids. Microbial transformations, peroxidases, copper oxidases, mouse and rat cytochrome P-450 systems, and mouse brain and bovine liver monoamine oxidase (MAO) preparations have been explored in the study of Catharanthus alkaloid metabolism. In this report, we present results which have clarified the involvement of enzymatic and chemically catalyzed one-electron oxidations that yield nitrogen-centered cation radicals, iminium, and carbinolamine intermediates, all of which explain how new carbon-carbon and carbon-oxygen bonds form, or break and rearrange. The dimeric Catharanthus alkaloids are recalcitrant to oxidations catalyzed by monoamine oxidases and to both normal and induced P-450 rat microsomal preparations. However, the Catharanthus alkaloids appear to be selective reversible inhibitors of MAO-B. Chemical and biochemical aspects of the metabolic transformations of dimeric Catharanthus alkaloids are reviewed together with the implications of our findings.</abstract><cop>Washington, DC</cop><cop>Glendale, AZ</cop><pub>American Chemical Society</pub><pmid>1593278</pmid><doi>10.1021/np50081a001</doi><tpages>16</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-3864 |
ispartof | Journal of natural products (Washington, D.C.), 1992-03, Vol.55 (3), p.269-284 |
issn | 0163-3864 1520-6025 |
language | eng |
recordid | cdi_crossref_primary_10_1021_np50081a001 |
source | ACS CRKN Legacy Archives |
subjects | AGENTES ANTINEOPLASTICOS ALCALOIDE ALCALOIDES ALKALOIDS Animals ANTINEOPLASTIC AGENTS APOCYNACEAE Biological and medical sciences DRUG TOXICITY DRUGS FARMACOLOGIA General pharmacology Humans Medical sciences MEDICAMENT MEDICAMENT CYTOSTATIQUE MEDICAMENTOS METABOLISM METABOLISME METABOLISMO Monoamine Oxidase - metabolism Monoamine Oxidase Inhibitors - pharmacology PHARMACODYNAMICS Pharmacognosy. Homeopathy. Health food PHARMACOLOGIE PHARMACOLOGY Pharmacology. Drug treatments TOXICIDAD TOXICITE TOXICITY Vinca Alkaloids - metabolism Vinca Alkaloids - pharmacology |
title | Metabolism of the Catharanthus Alkaloids: from Streptomyces griseus to Monoamine Oxidase B |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A01%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolism%20of%20the%20Catharanthus%20Alkaloids:%20from%20Streptomyces%20griseus%20to%20Monoamine%20Oxidase%20B&rft.jtitle=Journal%20of%20natural%20products%20(Washington,%20D.C.)&rft.au=Rosazza,%20John%20P.%20N&rft.date=1992-03-01&rft.volume=55&rft.issue=3&rft.spage=269&rft.epage=284&rft.pages=269-284&rft.issn=0163-3864&rft.eissn=1520-6025&rft.coden=JNPRDF&rft_id=info:doi/10.1021/np50081a001&rft_dat=%3Cistex_cross%3Eark_67375_TPS_01MB76PS_G%3C/istex_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a402t-b457a863e55cdee016a561abb5f29cb63151bb50e236ed43e004ea61a22cada03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/1593278&rfr_iscdi=true |